Evaluation of Cardiac, Autonomic Functions in Ambulant Patients with Duchenne Muscular Dystrophy

被引:2
|
作者
Amritharekha Nayak
Apoorva S B
Mainak Bardhan
R. Rashmi
G. Arunachal
P.V. Prathyusha
Atchayaram Nalini
T.N. Sathyaprabha
Kaviraja Udupa
机构
[1] National Institute of Mental Health And Neurosciences (NIMHANS),Department of Neurophysiology
[2] National Institute of Mental Health And Neurosciences (NIMHANS),Department of Neurology
[3] National Institute of Mental Health And Neurosciences (NIMHANS),Department of Human Genetics
[4] National Institute of Mental Health And Neurosciences (NIMHANS),Department of Biostatistics
关键词
Duchenne muscular dystrophy; Heart rate variability; Sinus tachycardia; Echocardiography;
D O I
10.1007/s42399-023-01473-5
中图分类号
学科分类号
摘要
Duchenne muscular dystrophy (DMD) is an X-linked genetic disorder caused by dystrophin gene mutation resulting in muscle weakness, motor delays, difficulty in standing, and inability to walk by 12 years. As disease progresses, it leads to cardiac and respiratory failure. Evaluation of cardiac autonomic status and echocardiography in DMD patients at a young age can be a potential biomarker to assess disease progression. This study aimed to investigate the younger DMD population of 5–11years of age with mild to moderate cardiac involvement for early detection using non-invasive and cost-effective tools. Genetically confirmed male DMD patients, aged 5–11 years (n = 47), screened from the outpatient department of a tertiary neuroscience institution were subjected to heart rate variability and echocardiographic analysis, and values were correlated with their clinical variables. DMD patients showed a significantly higher difference in HR, interventricular septum, E m/s, and E-wave to A-wave (E/A) ratio than normal values (p < 0.001). Significantly higher HR indicates initial sinus tachycardia and decreased IVD (d), and increased E m/s and E/A ratio mark the onset of cardiac symptoms in DMD patients even though its chamber dimension remains normal and are associated with cardiac muscle fibrosis.
引用
收藏
相关论文
共 50 条
  • [1] Evaluation of Cardiac Autonomic Dysfunction in Patients With Duchenne-type Muscular Dystrophy
    Yilmazer, Murat Muhtar
    Omeroglu, Rukiye Eker
    Bornaun, Helen
    Oner, Naci
    Nisli, Kemal
    [J]. JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH, 2010, 27 (01): : 12 - 19
  • [2] Autonomic dysfunction in patients with Duchenne muscular dystrophy
    Dello Russo, A
    De Luca, L
    De Martino, G
    Messano, L
    Giglio, V
    Mangiola, F
    Damiani, A
    Fumagalli, G
    Lanza, GA
    Bellocci, F
    [J]. EUROPEAN HEART JOURNAL, 2000, 21 : 552 - 552
  • [3] Autonomic function in patients with Duchenne muscular dystrophy
    Inoue, Miki
    Mori, Kazuhiro
    Hayabuchi, Yasunobu
    Tatara, Katsunori
    Kagami, Shoji
    [J]. PEDIATRICS INTERNATIONAL, 2009, 51 (01) : 33 - 40
  • [4] Evaluation of the North Star Ambulatory Assessment scale and cardiac abnormalities in ambulant boys with Duchenne muscular dystrophy
    Ergul, Yakup
    Ekici, Baris
    Nisli, Kemal
    Tatli, Burak
    Binboga, Fatih
    Acar, Gonul
    Ozmen, Meral
    Omeroglu, Rukiye Eker
    [J]. JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2012, 48 (07) : 610 - 616
  • [5] Preserved thenar muscles in non-ambulant Duchenne muscular dystrophy patients
    Naarding, Karin J.
    Keene, Kevin R.
    Sardjoe Mishre, Aashley S. D.
    Veeger, Thom T. J.
    van de Velde, Nienke M.
    Prins, Arina J.
    Burakiewicz, Jedrzej
    Verschuuren, Jan J. G. M.
    van der Holst, Menno
    Niks, Erik H.
    Kan, Hermien E.
    [J]. JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2021, 12 (03) : 694 - 703
  • [6] Impairment of cardiac autonomic function in patients with Duchenne muscular dystrophy: Relationship to myocardial and respiratory function
    Lanza, GL
    Dello Russo, A
    Giglio, V
    De Luca, L
    Messano, L
    Santini, C
    Ricci, E
    Damiani, A
    Fumagalli, G
    De Martino, G
    Mangiola, F
    Bellocci, F
    [J]. AMERICAN HEART JOURNAL, 2001, 141 (05) : 808 - 812
  • [7] Contracture management in ambulant boys with Duchenne muscular dystrophy (DMD)
    Moat, D.
    McCallum, M.
    Muni-Lofra, R.
    Wong, K.
    Michell-Sodhi, J.
    James, M.
    Michura, D.
    Richardson, M.
    Carden, G.
    Hall, C.
    Frith, K.
    Fitzsimmons, S.
    Marini-Bettolo, C.
    Mayhew, A.
    [J]. NEUROMUSCULAR DISORDERS, 2022, 32 : S97 - S98
  • [8] Outcome measures for Duchenne muscular dystrophy from ambulant to non-ambulant patients: implications for clinical trials
    Domingos, J.
    Eagle, M.
    Moraux, A.
    Butler, J.
    Decostre, V.
    Ridout, D.
    Mayhew, A.
    Selby, V.
    Guglieri, M.
    Van der Hoist, M.
    Jansen, M.
    Verschuuren, J.
    de Groot, I.
    Niks, E.
    Servais, L.
    Hogrel, J. Y.
    Straub, V.
    Voit, T.
    Ricotti, V.
    Muntoni, F.
    [J]. NEUROMUSCULAR DISORDERS, 2017, 27 : S232 - S233
  • [9] Evaluation and relevance of evaluation tools of cardiac function in Duchenne muscular dystrophy
    Park, Y.
    Moon, J.
    Im, S.
    [J]. NEUROMUSCULAR DISORDERS, 2007, 17 (9-10) : 815 - 816
  • [10] Patient perception of outcome measures for non-ambulant Duchenne muscular dystrophy patients
    Naarding, K.
    Van der Holst, M.
    Van de Velde, N.
    Van Schaik-Bank, P.
    Kan, H.
    Niks, E.
    [J]. NEUROMUSCULAR DISORDERS, 2019, 29 : S180 - S180